Can an App that Tracks Medication Doses and Mood Swings Help Improve Depression Treatment?

By |2021-11-11T17:04:51-08:00November 13th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

PHARMA NEWS Takeda and Lundbeck are planning a  U.S. test for a depression app that will track mood, in the hopes it will improve depression treatment. The two pharma companies have teamed up with Advocate Health Care on a study that uses an app with a “conversational text interface” to track and [...]

Brain Inflammation Tied to Depression and Suicidal Thoughts

By |2021-11-11T17:05:01-08:00November 13th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

On individuals with major depressive disorder (MDD), particularly those who experience suicidal thinking, levels of translocator protein (TSPO), a marker of microglial inflammation, are increased, new research shows. Investigators from the University of Manchester, United Kingdom, found significantly higher levels of TSPO in patients with MDD than in healthy control [...]

Effectiveness of Online Collaborative Care for Treating Mood and Anxiety Disorders in Primary Care: A Randomized Clinical Trial

By |2021-11-11T17:05:12-08:00November 13th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

By Bruce L. Rollman, Bea Herbeck Belnap, Biol Hum, Kaleab Z. Abebe Key Points Questions  Is combining an internet support group (ISG) with a care manager–guided computerized cognitive behavioral therapy (CCBT) program better at treating depression and anxiety than CCBT alone and better than primary care physicians’ usual care for these conditions? Findings  Among [...]

JAMA Issues Advance Directives for Dementia

By |2017-11-06T17:57:54-08:00November 6th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

Viewpoint November 6, 2017 Advance Directives for Dementia: Meeting a Unique Challenge By Barak Gaster, Eric B. Larson,  and J. Randall Curtis   In the coming years, an increasing number of people will experience dementia. Worldwide, the number of people living with dementia is projected to increase from 47 million in 2015 to 132 million by [...]

Plasticity and Its Association With Working Memory in Patients With Alzheimer Disease

By |2021-11-11T17:05:32-08:00October 28th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

Is dorsolateral prefrontal cortex plasticity impaired in Alzheimer disease? Yes, according to researchers writing in JAMA Psychiatry. Dorsolateral prefrontal cortex plasticity is impaired in Alzheimer disease and is associated with impaired working memory. Findings:  In this cross-sectional study of 32 participants with early Alzheimer disease and 16 healthy control participants, significant [...]

News Round-Up: Internet Porn Addiction, Suicide Attempts, Bipolar Disorder in Post-Dementia

By |2021-11-11T17:05:41-08:00October 27th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

Perceived Addiction to Internet Porn Examined Perceived addiction to internet pornography appears to be related strongly to moral scruples around pornography use, both concurrently and over time, rather than with the amount of daily pornography use itself, a recent study found. Participants were adults who had used pornography within the [...]

Medworks Media and Psychopharmacology Bulletin Launch a State-of-the-Art Digital Medical Platform

By |2021-11-11T17:05:49-08:00October 26th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

October 26, 2017 www.medworksmedia.com From: Michael E. Thase, MD, Editor-in-Chief & James M. La Rossa Jr., Editorial Director & Publisher — The Most Advanced Search Engine in Psychopharmacology — Comprehensive Library of Resources — New Databases: Psychopharmacology 101 and We Know Drugs   Medworks Media and Psychopharmacology Bulletin went live [...]

Research into Hallucinogens Gives Hope to the Hopeless and Fuels a Drug Epidemic: A Tale of Two Disparate Worlds

By |2021-11-11T17:05:57-08:00October 26th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

Alan F. Schatzberg, MD   Madness Rising Research into Hallucinogens Gives Hope to the Hopeless and Fuels a Drug Epidemic: A Tale of Two Disparate Worlds By James M. La Rossa Jr. Editorial Director and Publisher   In Robert Stone’s influential book about the heroin trade that permeated the Vietnam [...]

Association of Lithium in Drinking Water With the Incidence of Dementia

By |2021-11-11T17:06:32-08:00August 25th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

Original Investigation Association of Lithium in Drinking Water With the Incidence of Dementia Lars Vedel Kessing,  Thomas Alexander Gerds,  Nikoline Nygård Knudsen, Lisbeth Flindt Jørgensen, Søren Munch Kristiansen, Denitza Voutchkova, Vibeke Ernstsen, Jörg Schullehner, Birgitte Hansen, Per Kragh Andersen, Annette Kjær Ersbøll Question  Is a higher lithium level in drinking water associated with a decreased incidence of dementia? Findings  In this Danish nationwide, population-based, [...]

Go to Top